31 March 2022
16:00 – 17:30 CET

Link to online seminars: Zoom

The blockchain hype seems to be over. Based on the history of the two companies Camelot ITLab and Hypertrust Patient Data Care we will see how a blockchain network could have supported cell & gene therapies (case-study) and how blockchains indeed finally support them (productive solution).

Andreas is managing director and the technological driving-force behind Hypertrust Patient Data Care, a CAMELOT Group Company. After spending more than 15 years in different roles at SAP SE in Walldorf and several years in innovative technologies like blockchains, he combines these competences in his role at Hypertrust Patient Data Care to innovate patient-centric business applications for pharma and healthcare. Andreas firmly believes that healthcare digitalization has the power to positively transform today's patient experiences. Find out more: https://www.hypertrust-patient.com/